SHEPARD WILLIAM R purchased $3K of CME
SHEPARD WILLIAM R purchased 14 shares of CME GROUP INC. (CME) at $230.57 on 2026-06-25.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market purchase details (14 shares at $230.57) and post-transaction holdings (3,621 shares).
Market read
Traders may note the insider buy, but the transaction is small and does not introduce new operational or financial information.
What to watch
No 10b5-1 plan is stated, but the filing lacks context on intent, timing constraints, or whether this is part of a broader pattern.
Background
The article is an SEC Form 4 insider transaction disclosure for CME Group Inc.
Ticker impact
SEC Form 4 shows director SHEPARD WILLIAM R bought 14 shares of CME at $230.57 on 2026-06-25, totaling $3,301.30.
Likely minimal near-term impact; any effect is sentiment-only and small.
The filing is a small, non-material insider buy (14 shares) with no 10b5-1 plan and no accompanying company news.
Market effects
None; this is company-specific insider transaction with no sector datapoint.
None indicated.
None indicated.
Counterpoint
A director purchase can be interpreted as confidence, but the disclosed size is too small to meaningfully change valuation expectations.
Key entities
- issuerCME Group Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderSHEPARD WILLIAM R
Director who reported the open-market purchase.
